Bank of New York Mellon »

Tvardi Therapeutics shares owned by Bank of New York Mellon

Quarter-by-quarter ownership of Tvardi Therapeutics (TVRD) shares owned by Bank of New York Mellon from 13F filings

Historical chart of Bank of New York Mellon investment in Tvardi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tvardi Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tvardi Therapeutics by Bank of New York Mellon

Quarter filed Position value Share count Share price at filing
2025-09-30 $377k 9.7k 38.97

More positions owned by Bank of New York Mellon

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Broadcom (AVGO)
Ishares Core S&p 500 Etf Core (IVV)
Alphabet Cl A (GOOGL)
Alphabet CL C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Berkshire Hathaway Inc-cl B CL B (BRK.B)
Exxon Mobil Corporation (XOM)
Mastercard Inc - A Cl A (MA)
Johnson & Johnson (JNJ)

View all positions for Bank of New York Mellon

Top funds holding Tvardi Therapeutics

Slate Path Capital
Vanguard Group
BlackRock
683 Capital Management
Vestal Point Capital
Geode Capital Management
Invesco
FMR
Parkman Healthcare Partners
State Street Corporation
UBS Group
Farallon Capital Management
Northern Trust
Renaissance Technologies
Boothbay Fund Management

View all funds holding Tvardi Therapeutics